---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-105072"
form_type: "8-K"
ticker: "ONCO"
cik: "0001782107"
company_name: "Onconetix, Inc."
filed_at: "2024-12-03T23:59:59+00:00"
generated_at: "2026-05-29T09:57:27.163684+00:00"
event_type: "debt"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Onconetix obtains waiver of October payment to Veru; future payment percentage rises to 25%

## Summary
- Waives Oct 2024 cash receipt payment due Nov 20, 2024 until Onconetix receives at least $97,000 from Keystone equity line.
- In exchange, Onconetix increases Veru's share of net proceeds from future financings/strategic transactions to 25% (from 20%) through June 30, 2025.
- Onconetix states it lacks sufficient cash reserves to pay the October Cash Receipt Payments on time.
- Amendment executed November 26, 2024; extends forbearance terms under existing April 2024 note agreement.

## SEC filing metadata
- accession: 0001213900-24-105072
- form_type: 8-K
- ticker: ONCO
- cik: 0001782107
- company_name: Onconetix, Inc.
- filed_at: 2024-12-03T23:59:59+00:00
- event_type: debt
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1782107/000121390024105072/0001213900-24-105072-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1782107/000121390024105072/ea0223490-8k_onconetix.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-105072
- JSON: https://secwatch.observer/filing/0001213900-24-105072.json
- Plain text: https://secwatch.observer/filing/0001213900-24-105072.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.